The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

A new study published in the Nature Scientific Reports showed that compared to kidney recipients who got preemptive transplants, individuals who experienced dialysis prior to transplantation are ...

In July 2025, CSL Behring conducted a study in China is to investigate the pharmacokinetics (PK) of rVIII-SingleChain after ...

Senate hemp amendment to ban synthetics; VA secretary on psychedelics; DE gov tours marijuana grow; Another PA legalization bill Subscribe to receive Marijuana Moment’s newsletter in your inbox every ...

A review reveals dangerous vitamin deficiencies post-bariatric surgery, highlighting the need for improved follow-up to ...

A new study reveals that high eye pressure could be a key factor in the early stages of glaucoma, one of the top causes of ...

Meredith R. Klifto, MD, is an assistant professor of ophthalmology at the University of North Carolina School of Medicine, Chapel Hill. As a board-certified ophthalmologist, she specializes in ...

These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...

Hello, readers! Welcome to a bonus letters column. We are happy to report that you are keeping our inboxes busy, so we’ll dive right in.

George Medicines' Widaplik can address key challenges in current hypertension treatment, according to the UK drugmaker's CEO ...